Mode
Text Size
Log in / Sign up
N/A N=20 Treatment

Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study

Emergence Reaction · Procedural Sedation

Enrolled (actual)
20
Serious AEs
Results posted
Mar 2020
Primary outcome: Primary: Emergence Reaction

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Inhaled Nitrous Oxide (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Albert Einstein Healthcare Network
Primary completion
Apr 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Emergence Reaction
SECONDARY
Physiologic Measure
SECONDARY
Physiologic Measure
SECONDARY
Vitals
SECONDARY
Physician Interventions
SECONDARY
Level of Sedation
SECONDARY
Patient Recall of Procedure
SECONDARY
Total Ketamine Dose
SECONDARY
Total Time of Nitrous Use
SECONDARY
Physician Procedure Satisfaction Score
SECONDARY
Patient Procedure Satisfaction Score
SECONDARY
Nurse Procedure Satisfaction Score
SECONDARY
Length of ED Stay

Summary

To describe the safety and efficacy of nitrous oxide during ketamine administration for the prevention of emergence reaction during Emergency Department procedural sedation and analgesia in adults. Drugs such as fentanyl, midazolam, and propofol are widely used in emergency departments for procedural sedation and analgesia because they have a rapid onset and short duration of action. Unfortunately, all of these agents may cause respiratory depression, particularly when combined with other sedative agents, administered in large doses, or given to patients with underlying respiratory diseases. Nitrous oxide use during ketamine administration may be an ideal combination for the prevention of emergence reaction in adults sedated in the ED. Like ketamine, nitrous oxide has an excellent cardio-respiratory profile as well as some analgesic and anxiolytic qualities. The anxiety and pain surrounding procedural sedation is not limited to the procedure itself, but the elapsed time from the time the patient enters the ED to the time spent in preparation for the procedure can be significant and lead to increased anxiety, which may exacerbate emergence reactions in adults. Using nitrous oxide before ketamine administration may mitigate this. While midazolam has shown efficacy in reducing emergence reactions in adults sedated with ketamine, the investigators believe that inhaled nitrous oxide may be equivalent to midazolam, with a better cardio-respiratory profile.

Eligibility Criteria

Inclusion criteria: All spontaneously breathing subjects, 18 years of age and older, with an American Society of Anesthesiologists (ASA) Physical Status Classification 1 or 2, who will be receiving sedation for an ED procedure. Written informed consent will be obtained from all subjects. Exclusion criteria: Subjects with underlying conditions that could affect ventilation, perfusion, or metabolism including intubated subjects, subjects with clinical signs of cardiopulmonary instability, major trauma, thoracic trauma, shock, sepsis, psychiatric disorders and ASA class 3, 4, and 5. Also those unable to provide informed consent, nursing home residents, age less than 18 years, non English speaking, pregnant women, subjects under police custody, or physician discretion.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02145169). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search